Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications Read more about Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer Read more about Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results Read more about Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024 Read more about Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
Evoke Pharma Announces Closing of $7.5 Million Public Offering Read more about Evoke Pharma Announces Closing of $7.5 Million Public Offering
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million Read more about Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent Read more about Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent
United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI Read more about United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI
Evoke Pharma Reports Third Quarter 2023 Financial Results Read more about Evoke Pharma Reports Third Quarter 2023 Financial Results
Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healthcare Costs for Patients Using GIMOTI Over Oral Metoclopramide Presented at the American College of Gastroenterology 2023 Read more about Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healthcare Costs for Patients Using GIMOTI Over Oral Metoclopramide Presented at the American College of Gastroenterology 2023